Pathophysiology and Translational Research of Retinal Diseases
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 8448
Special Issue Editors
2. Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel
Interests: retina; phototransduction; clinical electrophysiology of vision; imaging; inherited retinal dystrophy; retinal drug toxicity; retinal light damage
Special Issue Information
Dear Colleagues,
The retina is the gate to visual perception. Photoreceptors convert light, entering the eye from the outside world, into neural signals which are then further processed in the inner retina and then transformed into patterns of electrical activity in the ganglion cells. The visual information is then transmitted to the brain for further analysis, eventually leading to the perception of pattern, color, and space localization.
Most cases of severe visual loss originate in the retina, including inherited disorders and acquired diseases. Most inherited visual disorders are caused by mutations in specific genes coding for proteins associated with the phototransduction process that involves the retinal pigment epithelium (RPE) cells and the photoreceptors. Other mutated genes encode for proteins associated with signal transduction from the photoreceptors to bipolar cells. Some of these diseases are degenerative in nature, eventually leading to blindness (e.g., retinitis pigmentosa), and others are associated with a stationary visual deficit (e.g., congenital stationary night blindness (CSNB) and achromatopsia). Acquired diseases are usually multifactorial and caused by genetic predisposition and non-genetic risk factors such as stress, exposure to light, diet, and more. An example of such a visual disorder is age-related macular dystrophy (AMD), the leading cause of blindness in the Western world, which is characterized by loss of central vision with preservation of peripheral vision.
Vision loss is devastating to the patient and is associated with a heavy burden to the family, to society, and to the economy. Therefore, many academic groups and biomedical companies are dedicated to studying the cellular and molecular mechanisms underlying retinal diseases and to developing novel therapeutic approaches.
This Special Issue of Bioengineering is dedicated to manuscripts focused on pathophysiology and translational research of retinal diseases. We accept manuscripts associated with basic, applied, and translational research on all aspects of retinal diseases, including inherited disorders and acquired diseases. Topics of interest include (but are not limited to) retinal pathophysiology, retinal cell biology, biological and non-biological means for vision restoration, and other related topics.
Prof. Dr. Ido Perlman
Prof. Dr. Yossi Mandel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal diseases
- pathophysiological mechanisms
- novel treatments
- visual restoration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.